Nicole T. Ansani

No ORCID on file · 5 papers in corpus · active 2022-2025

Study types

  • article 4
  • other 1

Condition tags

  • endometriosis 5
  • dysmenorrhea 2
  • chronic_pelvic_pain 2
  • dyspareunia 2
article 2025
Attribute preferences associated with gonadotropin-releasing hormone agonists/antagonists among women with endometriosis in the United States
Women's health (London, England) ·doi:10.1177/17455057251331700

BACKGROUND: Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, an…

other 2025
Social media to understand the endometriosis patient journey: Listening to influences driving treatment choices
Women's health (London, England) ·doi:10.1177/17455057241311765

BACKGROUND: Previous research has identified treatment attributes and outcomes for endometriosis patients, highlighting the need for tailored interventions to improve patient care. These studies emphasize the need to understand patient expe…

article 2023
RWD101 Treatment of Pain Due to Endometriosis in a Large US Medical Claims Dataset
·doi:10.1016/j.jval.2023.03.2130
article 2022
P-315 The importance of treatment features beyond pain reduction associated with gonadotropin-releasing hormone analogues from the patient perspective
·doi:10.1093/humrep/deac107.300

Abstract Study question Beyond reducing pain, how do women with moderate-severe-endometriosis pain prioritize treatment features and outcomes associated with gonadotropin-releasing hormone (GnRH) analogues? Summary answer Moderate-severe-en…

article 2022
PCR291 Preferences for Key Features of Gonadotropin-Releasing Hormone Analogues Among Women With Endometriosis in the United States
·doi:10.1016/j.jval.2022.09.2224